ThomasPatrickBeresfordMD
Psychiatry • Aurora, COAddiction, Psychosomatic Medicine
Professor, Psychiatry, University of Colorado School of Medicine
Dr. Beresford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 N. Wheeling Street (116)
Aurora, CO 80045Phone+1 720-723-7374
Education & Training
Cambridge Health AllianceResidency, Psychiatry, 1973 - 1976
University of Colorado School of Medicine Anschutz Medical CampusClass of 1973
Certifications & Licensure
CA State Medical License 1977 - 2026
CO State Medical License 1993 - 2025
MI State Medical License 1986 - 1993
TN State Medical License 1982 - 1986
WI State Medical License 1980 - 1983- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence Start of enrollment: 2008 Aug 01
- A Double-Blind, Controlled Study of Aripiprazole Versus Perphenazine in Co-Morbid Schizophrenia and Cocaine Dependence Start of enrollment: 2008 Oct 01
- Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury. Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 51 citationsThe Short‐Term Psychological Health of Alcoholic and Non‐Alcoholic Liver Transplant RecipientsThomas P. Beresford, Joseph Schwartz, Deborah Wilson, Robert M. Merion, Michael R. Lucey
Alcoholism, Clinical and Experimental Research. 1992-10-01 - 85 citationsComparative genomics of lactic acid bacteria reveals a niche-specific gene setOrla O'Sullivan, John O'Callaghan, Amaia Sangrador-Vegas, Olivia McAuliffe, Lydia Slattery
BMC Microbiology. 2009-03-05 - 116 citationsCollaborative Care for Bipolar Disorder: Part I. Intervention and Implementation in a Randomized Effectiveness TrialMark S. Bauer, M.S.N. Linda McBride, William O. Williford, Henry A. Glick, Bruce Kinosian
Psychiatric Services. 2006-07-01
Grant Support
- Neuro-Immunophyllin Ligand Mechanism Of Action In Reducing Alcohol PreferenceNational Institute On Alcohol Abuse And Alcoholism2008–2009
- Hippocampus/Pituitary Ratio: An AD Brain Injury Marker?National Institute On Alcohol Abuse And Alcoholism2004–2005
- Fatty Acid Ethyl Esters As An Indicator Of Ethanol UseNational Center For Research Resources2004
- Hippocampus /Pituitary Ratio And Alcohol DependenceNational Institute On Alcohol Abuse And Alcoholism2003
- Planning A Clinical Trial To Prevent Posttransplant ALDNational Institute On Alcohol Abuse And Alcoholism1998–1999
- Clinical Research Training In AlcoholismNational Institute On Alcohol Abuse And Alcoholism1990–1991
- Screening Examinations For Covert AlcoholismNational Institute On Alcohol Abuse And Alcoholism1986–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
